Polymorphisms in genes encoding leptin, ghrelin and their receptors in German multiple sclerosis patients

Molecular and Cellular Probes

Volumn 25, Issue 5-6, 2011, Pages 255-259

  Rey, Linda K ^a   Wieczorek, Stefan ^a   Akkad, Denis A ^a   Linker, Ralf A ^b   Chan, Andrew ^b,c   Hoffjan, Sabine ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Genetic association; Ghrelin; Leptin; Multiple sclerosis; Polymorphism

Indexed keywords

GHRELIN; GHRELIN RECEPTOR; GROWTH HORMONE SECRETAGOGUE RECEPTOR; LEPTIN; LEPTIN RECEPTOR;

ADULT; ALLELE; ARTICLE; AUTOIMMUNE DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENERGY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMEOSTASIS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYNDROME; WEGENER GRANULOMATOSIS;

ADULT; ALLELES; CASE-CONTROL STUDIES; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERMANY; GHRELIN; HAPLOTYPES; HUMANS; LEPTIN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, GHRELIN; RECEPTORS, LEPTIN;

EID: 80055092164     PISSN: 08908508     EISSN: 10961194     Source Type: Journal    
DOI: 10.1016/j.mcp.2011.05.004     Document Type: Article

References (34)

1. Baranzini S.E., Wang J., Gibson R.A., Galwey N., Naegelin Y., Barkhof F., et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet 2009, 18:767-778.
2. Lublin F.D., Reingold S.C. Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: relations between study investigators, advisors, and sponsors. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1997, 48:572-574.
3. Sawcer S. The complex genetics of multiple sclerosis: pitfalls and prospects. Brain 2008, 131:3118-3131.
4. Oksenberg J.R., Barcellos L.F. Multiple sclerosis genetics: leaving no stone unturned. Genes Immun 2005, 6:375-387.
5. Oksenberg J.R., Baranzini S.E., Sawcer S., Hauser S.L. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet 2008, 9:516-526.
6. Hoffjan S., Akkad D.A. The genetics of multiple sclerosis: an update 2010. Mol Cell Probes 2010, 24:237-243.
7. Nogueiras R., Tschop M.H., Zigman J.M. Central nervous system regulation of energy metabolism: ghrelin versus leptin. Ann N Y Acad Sci 2008, 1126:14-19.
8. Matarese G., Leiter E.H., La Cava A. Leptin in autoimmunity: many questions, some answers. Tissue Antigens 2007, 70:87-95.
9. Thewissen M., Cohen Tervaert J.W. Leptin and ANCA-associated vasculitis: a healthy link?. Rheumatology (Oxford) 2008, 47:387-389.
10. De Rosa V., Procaccini C., La Cava A., Chieffi P., Nicoletti G.F., Fontana S., et al. Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis. J Clin Invest 2006, 116:447-455.
11. Matarese G., Carrieri P.B., La Cava A., Perna F., Sanna V., De Rosa V., et al. Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells. Proc Natl Acad Sci U S A 2005, 102:5150-5155.
12. Sanna V., Di Giacomo A., La Cava A., Lechler R.I., Fontana S., Zappacosta S., et al. Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J Clin Invest 2003, 111:241-250.
13. Batocchi A.P., Rotondi M., Caggiula M., Frisullo G., Odoardi F., Nociti V., et al. Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta. J Neuroimmunol 2003, 139:150-154.
14. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 2002, 8:500-508.
15. Chatzantoni K., Papathanassopoulos P., Gourzoulidou E., Mouzaki A. Leptin and its soluble receptor in plasma of patients suffering from remitting-relapsing multiple sclerosis (MS) In vitro effects of leptin on type-1 and type-2 cytokine secretion by peripheral blood mononuclear cells, T-cells and monocytes of MS patients. J Autoimmun 2004, 23:169-177.
16. Frisullo G., Mirabella M., Angelucci F., Caggiula M., Morosetti R., Sancricca C., et al. The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. J Neuroimmunol 2007, 192:174-183.
17. Theil M.M., Miyake S., Mizuno M., Tomi C., Croxford J.L., Hosoda H., et al. Suppression of experimental autoimmune encephalomyelitis by ghrelin. J Immunol 2009, 183:2859-2866.
18. Wieczorek S., Holle J.U., Bremer J.P., Wibisono D., Moosig F., Fricke H., et al. Contrasting association of a non-synonymous leptin receptor gene polymorphism with Wegener's granulomatosis and Churg-Strauss syndrome. Rheumatology (Oxford) 2010, 49:907-914.
19. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the " McDonald Criteria" Ann Neurol 2005, 58:840-846.
20. Wieczorek S., Hoffjan S., Chan A., Rey L., Harper L., Fricke H., et al. Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple sclerosis in German patients. Genes Immun 2009, 10:591-595.
21. Gauderman W.J. Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 2002, 155:478-484.
22. Matarese G., Procaccini C., De Rosa V. The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis?. J Leukoc Biol 2008, 84:893-899.
23. La Cava A., Matarese G. The weight of leptin in immunity. Nat Rev Immunol 2004, 4:371-379.
24. Zhernakova A., van Diemen C.C., Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 2009, 10:43-55.
25. Lettre G., Rioux J.D. Autoimmune diseases: insights from genome-wide association studies. Hum Mol Genet 2008, 17:R116-121.
26. Utsunomiya K., Shinkai T., Sakata S., Hwang R., Yamada K., Chen H.I., et al. Lack of association between the leptin receptor gene (LEPR) Gln223Arg polymorphism and late-onset Alzheimer disease. Alzheimer Dis Assoc Disord 2010, 24:101-103.
27. Garcia E.A., King P., Sidhu K., Ohgusu H., Walley A., Lecoeur C., et al. The role of ghrelin and ghrelin-receptor gene variants and promoter activity in type 2 diabetes. Eur J Endocrinol 2009, 161:307-315.
28. Robledo G., Rueda B., Gonzalez-Gay M.A., Fernandez B., Lamas J.R., Balsa A., et al. Association study of ghrelin receptor gene polymorphisms in rheumatoid arthritis. Clin Exp Rheumatol 2010, 28:25-29.
29. Hermanowski J., Bouzigon E., Forabosco P., Ng M.Y., Fisher S.A., Lewis C.M. Meta-analysis of genome-wide linkage studies for multiple sclerosis, using an extended GSMA method. Eur J Hum Genet 2007, 15:703-710.
30. Alcina A., Vandenbroeck K., Otaegui D., Saiz A., Gonzalez J.R., Fernandez O., et al. The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis. Genes Immun 2010, 11:439-445.
31. Mardis E.R. The impact of next-generation sequencing technology on genetics. Trends Genet 2008, 24:133-141.
32. Goodin D.S. The causal cascade to multiple sclerosis: a model for MS pathogenesis. PLoS One 2009, 4:e4565.
33. Uher R. Gene-environment interaction: overcoming methodological challenges. Novartis Found Symp 2008, 293:13-26. discussion 26-30, 68-70.
34. Martinez A., Alvarez-Lafuente R., Mas A., Bartolome M., Garcia-Montojo M., de Las Heras V., et al. Environment-gene interaction in multiple sclerosis: human herpesvirus 6 and MHC2TA. Hum Immunol 2007, 68:685-689.